Price T Rowe Associates Inc West Pharmaceutical Services Inc Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 117,629 shares of WST stock, worth $28.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,629

Previous 154,751 23.99%

Holding current value

$28.2 Million

Previous $34.6 Million 25.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$190.39 - $227.7 $7.07 Million - $8.45 Million	-37,122 Reduced 23.99%	117,629 $25.7 Million
Q1 2025 May 14, 2025	SELL	$199.11 - $347.87 $73.8 Million - $129 Million	-370,568 Reduced 70.54%	154,751 $34.6 Million
Q4 2024 Feb 14, 2025	SELL	$285.69 - $344.0 $210 Million - $253 Million	-736,159 Reduced 58.36%	525,319 $172 Million
Q3 2024 Nov 14, 2024	SELL	$277.16 - $333.3 $120 Million - $144 Million	-432,349 Reduced 25.52%	1,261,478 $379 Million
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $107 Million - $134 Million	-339,063 Reduced 16.68%	1,693,827 $558 Million
Q1 2024 May 15, 2024	SELL	$338.27 - $413.0 $99.6 Million - $122 Million	-294,504 Reduced 12.65%	2,032,890 $804 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $57.2 Million - $70.5 Million	-179,742 Reduced 7.17%	2,327,394 $820 Million
Q3 2023 Nov 14, 2023	SELL	$354.9 - $412.41 $117 Million - $136 Million	-330,808 Reduced 11.66%	2,507,136 $941 Million
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $1.59 Million - $1.82 Million	-4,757 Reduced 0.17%	2,837,944 $1.09 Billion
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $126 Million - $188 Million	541,540 Added 23.53%	2,842,701 $985 Million
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $328 Million - $410 Million	-1,568,961 Reduced 40.54%	2,301,161 $542 Million
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $585 Million - $817 Million	-2,377,451 Reduced 38.05%	3,870,122 $952 Million
Q2 2022 Aug 15, 2022	SELL	$280.61 - $420.45 $37.5 Million - $56.1 Million	-133,485 Reduced 2.09%	6,247,573 $1.89 Billion
Q1 2022 May 16, 2022	BUY	$357.49 - $445.92 $49.7 Million - $62.1 Million	139,157 Added 2.23%	6,381,058 $2.62 Billion
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $463 Million - $543 Million	1,151,427 Added 22.62%	6,241,901 $2.93 Billion
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $90 Million - $116 Million	-247,898 Reduced 4.64%	5,090,474 $2.16 Billion
Q2 2021 Aug 16, 2021	BUY	$284.77 - $363.2 $92.6 Million - $118 Million	325,327 Added 6.49%	5,338,372 $1.92 Billion
Q1 2021 May 17, 2021	BUY	$257.29 - $307.53 $100 Million - $120 Million	388,798 Added 8.41%	5,013,045 $1.41 Billion
Q4 2020 Feb 16, 2021	BUY	$261.16 - $301.66 $1.21 Billion - $1.39 Billion	4,624,247 New	4,624,247 $1.31 Billion

Others Institutions Holding WST

# of Institutions

816

Shares Held

68.6M

Call Options Held

344K

Put Options Held

144K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $17.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc West Pharmaceutical Services Inc Transaction History